NADINA trial results support a new standard of care for these patients.
2024
Exciting Progress for Difficult-to-Treat Advanced Melanoma — What to Know About Biologic Drug Brenetafusp
An exciting biologic drug called brenetafusp is being studied, and showing real promise, in treating advanced cutaneous melanoma.
RELATIVITY-048: Triplet Immunotherapy Shows Activity in Untreated Advanced Melanoma
As a first-line treatment of advanced melanoma, the triplet immunotherapy regimen of nivolumab, relatlimab-rmbw, and ipilimumab produced high response rates and promising progression-free and overall survival in the nonrandomized phase I/II RELATIVITY-048 trial, as reported by Paolo Antonio Ascierto, MD, of the Istituto Nazionale dei Tumori IRCCS in Naples, Italy, at the 2024 ASCO Annual Meeting.
Melanoma Brain Metastases: New Study Offers Insight for More Effective Cancer Treatment
For those living with advanced melanoma, brain metastases— malignant growths that occur when cancer cells travel to the brain—are particularly challenging to treat.